Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on ...

Company has Suresh Surana & Associates LLP as its auditors. As on 31-03-2025, the company has a total of 28.22 Crore shares outstanding.Glenmark Pharma Share Price Today is Rs. 1412.50. On previous ...

Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...

The Trump Administration is reportedly mulling over a policy to match U.S. drug prices with those in other developed nations.

US Stock Futures Slide as Tariff-Fueled Market Meltdown Continues ...

Drugmakers have been warned that the Trump Administration is considering linking U.S. medicine prices to lower amounts paid ...

Westbury’s school district is continuing its tradition of leveraging lawsuits to advocate for the school’s community.

Novo Nordisk (NYSE: NVO) stock hit an all-time high of $148.15 in June 2024, marking a remarkable fivefold surge since 2019.

A unique Novo Nordisk legal challenge to the Medicare drug pricing program could have big implications for the pharma ...

President Donald Trump's latest executive order outlines the administration's plan to lower costs for healthcare. The plan ...